Compare iShares MSCI Japan ETF (EWJ) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Japan ETF vs Revvity Inc — how do they compare? iShares MSCI Japan ETF trades at $97.85, while Revvity Inc trades at $117.6 (market cap $12.91B). The key difference: Revvity Inc pays a 0.24% dividend while iShares MSCI Japan ETF pays none. Which is the better fit depends on your goals.
| EWJ | RVTY | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $96.97 | $117.75 |
52-Week Low | $77.93 | $82.26 |
Market Cap | — | $12.91B |
Enterprise Value | — | $15.23B |
Dividend Yield | — | 0.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWJ, the iShares MSCI Japan ETF, trades at $97.79, up 1.81% today, with a bullish technical signal driven by strong moving average alignment. The fund's performance is influenced by Japanese economic policies, including recent U.S.-Japan currency intervention and domestic stimulus efforts. Key resistance sits at $97, with support at $96. Recent news highlights focus on yen strength and its impact on export-heavy Japanese equities.
The outlook for EWJ is cautiously optimistic, supported by bullish technicals and potential economic tailwinds from Japanese fiscal policy. Risks include yen volatility, export sensitivity to currency moves, and broader Asian market turbulence. Investor sentiment is mixed, balancing policy support against inflation and growth concerns.
RVTY trades at $117.88, up 1.6% today, with a bullish technical outlook and strong earnings momentum after beating Q2 2026 EPS estimates. The stock is near the consensus price target of $120.50, supported by a 51.72% analyst buy rating. Recent news highlights product launches like the SuperFlex prenatal system and investor conference participation, reinforcing growth prospects in diagnostics and biotech tools.
The outlook remains positive with revenue stability and margin strength, but elevated P/E of 55.64 poses valuation risk. Key opportunities include diagnostic demand and AI-driven workflows, while risks involve competitive pressures and execution challenges. Net cash flow turned positive in 2026, signaling improved financial health.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI Japan ETF
EWJ tracks the MSCI Japan Index, providing broad exposure to over 180 large and mid-cap companies in Japan. It is the most established and liquid vehicle for accessing the Japanese equity market, featuring a diversified portfolio across industrials, consumer discretionary, and financial sectors.
Read more on EWJ →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
